T3 Defense Inc. (DFNS) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by T3 Defense Inc. on April 10, 2026. The report details the completion of a significant asset disposition by Water IO Ltd. ("Water IO"), an Israeli public company in which T3 Defense holds an approximately 67% equity interest through its wholly-owned subsidiary, Star 26 Capital Inc.
Key Financial Metrics and Transaction Details
The filing reports the sale of 100% of the issued and outstanding share capital of Zorro Net Ltd. ("Zorronet"), a wholly-owned subsidiary of Water IO, to BiomX Inc. (NYSE American: PHGE). The consideration received by Water IO includes:
- Equity: 1,300,000 shares of BiomX common stock.
- Debt Instrument: A non-convertible promissory note with a principal amount of $1,250,000, bearing interest at the short-term applicable federal rate, maturing three months from issuance.
- Contingent Consideration: A performance-based earnout payable no later than March 31, 2027, equal to the greater of 125% of Zorronet's consolidated revenue or eight times Zorronet's consolidated EBITDA for fiscal year 2026.
As a result of the transaction, Water IO holds approximately 16.57% of BiomX's issued and outstanding common stock. T3 Defense may be deemed to beneficially own these shares indirectly through its 67% stake in Water IO.
Material Changes and Operational Impact
Zorronet, an Israeli artificial intelligence defense technology company specializing in AI-powered computer vision and autonomous surveillance systems, has been divested. The company's technology was previously deployed at Israel Defense Forces (IDF) bases and critical national infrastructure sites. BiomX has assumed certain obligations regarding Zorronet's founders and former shareholders, including a commitment to retain key personnel for three years on no less favorable terms.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue projections, or liquidity metrics for T3 Defense Inc. itself. The primary risk and contingency noted is the performance-based earnout, which depends on Zorronet's fiscal year 2026 consolidated revenue or EBITDA. The transaction is subject to the terms of the Stock Purchase Agreement dated April 10, 2026.
Key Facts for Investor Verification
- Verify the current market value of the 1,300,000 BiomX shares received by Water IO.
- Confirm the valuation of the $1,250,000 promissory note and its interest accrual terms.
- Assess the likelihood and potential value of the earnout based on Zorronet's 2026 performance metrics.
- Review the full text of the Stock Purchase Agreement (Exhibit 10.52) for additional covenants or restrictions.
- Monitor the impact of the divestiture on Water IO's consolidated financial statements and T3 Defense's indirect ownership value.